BNB, the native token that powers the vinance ecosystem, has reached a new milestone amid renewed market interest and institutional activity.
On July 28th, the digital assets temporarily eased their record price to around $854, before relaxing to around $847.5 at the time of writing.
This latest surge shows a daily increase of 7%, winning a month-long 32% rallies, exceeding BNB’s market capitalization of over $115 billion. The market capitalization of Binance-Linked Tokens has overturned the market capitalization of Nike, the world’s largest shoe company.
The strong momentum appears to coincide with bullish predictions from analysts, including Standard Chartered, which had predicted BNB could rise above $1,000 this year.
Furthermore, growth in token derivatives activities adds token bullish sentiment in the market.
BNB’s open profit, Active Futures contract, totaled an all-time high of $1.7 billion, according to Coinglass data.
This shows increased training engagement and increased confidence in the long-term outlook for tokens, surpassing the December 2024 peak.
More than $1 billion is planned for BNB’s institutional acquisition
Meanwhile, BNB rallies are drawing more than mere retail enthusiasm as some institutional investors are increasingly positioning themselves for their long-term exposure.
On July 28th, CEA Industries Inc. (NASDAQ: VAPE) announced plans to launch the world’s largest publicly listed BNB financial strategy.
CEA aims to become the first regulatory, US registered finance company focused on BNB. Supported by 10x capital and YZI Labs.
The company has $500 million private property and includes a $100 million crypto allocation. If a warrant is made, the total transaction could reach $1.25 billion.
More than 140 institutions have already taken part in the transaction, including Pantera Capital, GSR, DAO5 and Arington Capital, according to the press conference.
Russell Reid, CEA CIO, said:
“By creating financial vehicles, we are enabling institutions to participate in their growth narratives in a way that is consistent with the need for transparency and long-term value, rather than short-term trading opportunities.”
In addition to the wave of institutional interest, there is Liminatus Pharma, a US-based biotechnology company.
The company has announced plans to launch a dedicated investment division, American BNB Strategy. This will unfold over time to up to $500 million BNBs.
The initiative, according to the company, comes from an internal review of the blockchain integrated financial model and reflects BNB’s trust in infrastructure, security, and growth trajectory.
Liminatus CEO Chris Kim said:
“This is not a short-term speculative initiative, but a value-driven strategy based on the long-term growth potential and strength of the BNB ecosystem.”
It is mentioned in this article
